|
CDRH Announces its 2022-2025 Strategic Priorities
Today, the U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) announced its 2022-2025 Strategic Priorities focusing on three priority areas. The Center established clear goals and measures of success for the overarching device program and each strategic priority. CDRH’s measures of success will show the Center’s progress toward its commitment to the American people that patients have access to high-quality, safe, and effective medical devices.
As outlined in the three 2022-2025 Strategic Priorities, CDRH intends to:
- Promote a Modern and Diverse Workforce
- Enhance Organizational Agility and Resilience
- Advance Health Equity
Questions?
If you have questions about the CDRH 2022-2025 Strategic Priorities, please contact the Division of Industry and Consumer Education.
|
